Status:
COMPLETED
Comparing the Protective Effects of Two Cardioplegic Solutions, on Cardiac Metabolism, as Assessed Using Microdialysis
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Collaborating Sponsors:
Jazz Pharmaceuticals
Association AIRE (FR)
Conditions:
Coronary Artery Stenosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
An estimated 8% to 15% of patients hospitalized for a coronary pathology undergo coronary revascularization surgery with extracorporeal circulation (ECC). (1) Like most major cardiac surgical interven...
Detailed Description
Myocardial microdialysis is the state-of-the-art technique for evaluating the protective effects of cardioplegic solutions; it enables physicians to monitor oxidation-reduction muscle metabolism durin...
Eligibility Criteria
Inclusion
- Patient was referred to the Cardiovascular Surgery Unit for surgical coronary revascularization
- Patient has anterior interventricular stenosis
- Patient signed the informed consent form
- Patient is covered by health insurance
Exclusion
- Patients with beating heart surgery indication (no extracorporeal circulation required)
- Emergency surgery and patients who suffered myocardial infarction less than a week before surgery
- Iterative surgery
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT01401140
Start Date
June 1 2010
End Date
March 1 2012
Last Update
March 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Saint-Eienne
Saint-Etienne, France, 42000